Life Scientist > Biotechnology

Canola pollen travels... but doesn't do much when it arrives

01 July, 2002 by Melissa Trudinger

Pollen from a herbicide-tolerant canola crop spreads to neighbouring fields, according to Australian study published in the June 28th issue of Science, but only a very low percentage of plants are fertilised there.


Varian to open HPLC production facility in Melbourne

28 June, 2002 by Tanya Hollis

Victoria has won a key investment in a $US200 million coup that sees a Silicon Valley production facility shift its base to Melbourne's east.


Xcell appoints regulatory team for US, Europe push

27 June, 2002 by Tanya Hollis

Perth-based devices group Xcell Diagnostics has gathered up a specialised regulatory affairs team to drive United States and European registration of its Funhaler product.


GM sensitivities force caution on biotech R&D

27 June, 2002 by Pete Young

Consumer sensitivities over genetically modified foods are forcing biotech researchers in Australia's sugar industry to walk a tightrope.


Cochlear implant upgrades should be free: Labor MP

26 June, 2002 by Tanya Hollis

Hearing impaired Australians should have access to free cochlear implant processor upgrades, according to a Labor MP.


New respiratory medicine exchange program

25 June, 2002 by Melissa Trudinger

A million-dollar grant from GlaxoSmithKline has allowed the Institute of Respiratory Medicine to set up a scientist exchange program to allow Australian scientists to travel and work overseas and to bring international scientists to work at the institute.


AIMS solves mystery poison puzzle

25 June, 2002 by Melissa Trudinger

An Australian researcher at the Australian Institute of Marine Science (AIMS) has solved the medical mystery of the death of an East Timorese man from what appeared to be poisoning in late 2000.


R&D Start freeze could shelve cancer project

24 June, 2002 by Tanya Hollis

A Western Australian research project into the use of carotenoids as a treatment for prostate cancer has been shelved because of the halt to the Federal government's R&D Start program.


Mandatory food labelling, testing laws unworkable: ANZFA

24 June, 2002 by Tanya Hollis

Mandatory, industry-wide food labelling laws would be unworkable and create huge costs for businesses and consumers, according to Australia's peak food authority.


Award kudos for Flinders bioengineers

21 June, 2002 by Claire Doble

Biomedical engineering breakthroughs are being achieved at Flinders University. The latest achievement, a bioengineered epidural simulator, has resulted in an Institute of Electrical Engineers (IEE) award for the researcher, postgrad student Olivia Pallotta.


BioFocus lifts stake in AustCancer

21 June, 2002 by Melissa Trudinger

Australian Cancer Technology's joint venture partner BioFocus has strengthened the alliance between the two companies by increasing its holding to more than three per cent.


Tas study shows GM regrowth rare

21 June, 2002 by Tanya Hollis

The latest audit of genetically modified crop sites in Tasmania has shown 60 per cent of sites have remained free of re-growth after more than nine months.


Chemeq claims chicken growth success in antimicrobial tests

20 June, 2002 by Melissa Trudinger

An independent study using a polymeric antimicrobial designed by Perth-based biotech Chemeq has demonstrated increased growth rates in chickens at 10 per cent of the dose originally tested in poultry, according to the company.


Autogen discovers gene link between heart disease and diabetes

20 June, 2002 by Tanya Hollis

Gene-discovery company Autogen (ASX: AGT) has discovered a genetic link between diabetes and heart diseases in humans.


BioProspect insecticide set for global field trials

20 June, 2002 by Tanya Hollis

A natural Western Australian insecticide is to be tested in field trials across Australia, Asia the United States and Europe under an agreement between BioProspect and Nufarm.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd